<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30254034</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Annals of the rheumatic diseases</Title><ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation></Journal><ArticleTitle>Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification.</ArticleTitle><Pagination><StartPage>380</StartPage><EndPage>390</EndPage><MedlinePgn>380-390</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2018-214125</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The generation of systemic lupus erythematosus (SLE)-related autoantibodies have been shown to be T cell dependent and antigen driven with HLA-DR restriction. In this study, the initiating antigen(s) and the mechanism of autoantibody diversification were investigated.</AbstractText><AbstractText Label="METHODS">T cell epitopes (T-epitopes) of SmD1 (SmD) were mapped by T-T hybridomas generated from DR3<sup>+</sup>AE<sup>0</sup> mice immunised with SmD and with SmD overlapping peptides. TCRs from the reactive hybridomas were sequenced. The core epitopes were determined. Bacterial mimics were identified by bioinformatics. Sera from DR3<sup>+</sup>AE<sup>0</sup> mice immunised with SmD peptides and their mimics were analysed for their reactivity by ELISA and immunohistochemistry. Samples of blood donors were analysed for HLA-DR and autoantibody specificities.</AbstractText><AbstractText Label="RESULTS">Multiple HLA-DR3 restricted T-epitopes within SmD were identified. Many T-T hybridomas reacted with more than one epitope. Some of them were cross-reactive with other snRNP peptides and with proteins in the Ro60/La/Ro52 complex. The reactive hybridomas used unique TCRs. Multiple T-epitope mimics were identified in commensal and environmental bacteria. Certain bacterial mimics shared both T and B cell epitopes with the related SmD peptide. Bacterial mimics induced autoantibodies to lupus-related antigens and to different tissues. HLA-DR3<sup>+</sup> blood donors made significantly more SLE-related autoantibodies.</AbstractText><AbstractText Label="CONCLUSIONS">The unique antigenic structures of the lupus-related autoantigens provide the basis for being targeted and for T and B cell epitope spreading and autoantibody diversification with unique patterns. SLE-related autoantibodies are likely generated from responses to commensal and/or environmental microbes due to incomplete negative selection for autoreactive T cells. The production of SLE-related antibodies is inevitable in normal individuals. The findings in this investigation have significant implications in autoimmunity in general.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Zhenhuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ren</LastName><ForeName>Jiling</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannapell</LastName><ForeName>Carol C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongyang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaskin</LastName><ForeName>Felicia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Shu Man</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA sf2e@virginia.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI139673</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR047988</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK105833</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Rheum Dis</MedlineTA><NlmUniqueID>0372355</NlmUniqueID><ISSNLinking>0003-4967</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018984">Epitopes, T-Lymphocyte</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055517">snRNP Core Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Rheum Dis. 2019 Mar;78(3):291-292</RefSource><PMID Version="1">30352889</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018984" MajorTopicYN="N">Epitopes, T-Lymphocyte</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006684" MajorTopicYN="N">HLA-DR Antigens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055517" MajorTopicYN="N">snRNP Core Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HLA-DR</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">T cell epitopes</Keyword><Keyword MajorTopicYN="N">autoantibody</Keyword><Keyword MajorTopicYN="N">molecular mimicry</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30254034</ArticleId><ArticleId IdType="mid">NIHMS1006440</ArticleId><ArticleId IdType="pmc">PMC6377330</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2018-214125</ArticleId><ArticleId IdType="pii">annrheumdis-2018-214125</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC. Systemic lupus erythematosus. N EnglJ Med 2011;365:21 10&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">14561795</ArticleId></ArticleIdList></Reference><Reference><Citation>Craft J Antibodies to snRNPs in systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:311&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">1626072</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, Scofield RH, Reichlin M. Anti-Ro in Sj&#xf6;gren&#x2019;s syndrome and systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:337&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">1626073</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham RR, Ortmann W, Rodine P, et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 2007;15:823&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">17406641</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh NJ, Owen P, Cox B, et al. MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus. Ann Rheum Dis 2006;65:488&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1798099</ArticleId><ArticleId IdType="pubmed">16107511</ArticleId></ArticleIdList></Reference><Reference><Citation>Rood MJ, van Krugten MV, Zanelli E, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheurri 2000;43:129&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">10643708</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, Deshmukh US, Gaskin F, et al. Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens. J Immunol 2010;184:1085&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2842881</ArticleId><ArticleId IdType="pubmed">20007529</ArticleId></ArticleIdList></Reference><Reference><Citation>Paisansinsup T, Deshmukh US, Chowdhaiy VR, et al. HLA class II Influences the Immune response and antibody diversification to Ro60/Sj&#xf6;gren&#x2019;s syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J Immunol 2002;168:5876&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">12023392</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhary VR, Dai C, Tilahun AY, et al. A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus. J Immunol 2015;195:4660&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5292932</ArticleId><ArticleId IdType="pubmed">26475924</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh US, Sim DL, Dai C, et al. HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD. J Autoimmun 2011;37:254&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372418</ArticleId><ArticleId IdType="pubmed">21868195</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan G, lijima K, Singh M, et al. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun 2006;74:1284&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1360368</ArticleId><ArticleId IdType="pubmed">16428778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruisbeek AM. Production of mouse T cell hybridomas. CurrProtocImmunol 2001;Chapter 3:Unit 3.14.</Citation><ArticleIdList><ArticleId IdType="pubmed">18432780</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, Rowen L, Hood L, et al. Differential transcriptional regulation of individual TCR V beta segments before gene rearrangement. J Immunol 2001;166:1771&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">11160223</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunce M PCR-sequence-specific primer typing of HLA class I and class II alleles. Methods Mol Biol 2003;210:143&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">12412454</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen JA, Fu SM, Antonelli P, et al. B-Lymphoid cell lines derived fromHLA-D homozygous donors. Immunogenetics 1979;8:51&#x2013;64.</Citation></Reference><Reference><Citation>Fu SM, Deshmukh US, Gaskin F. Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J Autoimmun 2011;37:104&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173577</ArticleId><ArticleId IdType="pubmed">21632208</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R, Deshmukh US, Ohyama Y, et al. Evidence for multiple shared antigenic determinants within Ro60 and other lupus-related ribonucleoprotein autoantigens in human autoimmune responses. J Immunol 2005;175:7669&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">16301677</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh US, Bagavant H, Sim D, et al. A SmD peptide induces better antibody responses to other proteins within the small nuclear ribonucleoprotein complex than to SmD protein via intermolecular epitope spreading. J Immunol 2007;178:2565&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">17277166</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymula A, Rosenthal J, Szczerba BM, et al. T cell epitope mimicry between Sj&#xf6;gren&#x2019;s syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol 2014;152(1&#x2013;2):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4004658</ArticleId><ArticleId IdType="pubmed">24576620</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters ST, McDuffie M, Bagavant H, et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004;199:255&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2211766</ArticleId><ArticleId IdType="pubmed">14718514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y, Jiang C, Sung SS, et al. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J Exp Med 2013;210:2387&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3804943</ArticleId><ArticleId IdType="pubmed">24101379</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai C, Deng Y, Quinlan A, et al. Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage. Curr Opin Immunol 2014;31:87&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4274270</ArticleId><ArticleId IdType="pubmed">25458999</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaratino S, Thorpe CJ, Travers PJ, et al. Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. Proc Natl Acad Sci U S A 1995;92:10398&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40804</ArticleId><ArticleId IdType="pubmed">7479792</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao CC, Sytwu HK, Chen EL, et al. The role of MHC class II molecules In susceptibility to type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire. Proc Natl Acad Sci U S A 1999;96:9299&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC17775</ArticleId><ArticleId IdType="pubmed">10430937</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Wang B, Frelinger JA, et al. T-cell promiscuity in autoimmune diabetes. Diabetes 2008;57:2099&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2494676</ArticleId><ArticleId IdType="pubmed">18492786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono DH, Urban JL, Horvath SJ, et al. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J Exp Med 1988;168:213&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2188984</ArticleId><ArticleId IdType="pubmed">2456367</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutoit V, Rubio-Godoy V, Pittet MJ, et al. Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans. J Exp Med 2002;196:207&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193921</ArticleId><ArticleId IdType="pubmed">12119345</ArticleId></ArticleIdList></Reference><Reference><Citation>De Silva-Udawatta M, Kumar SR, Greidinger EL, et al. Cloned human TCR from patients with autoimmune disease can respond to two structurally distinct autoantigens. J Immunol 2004;172:3940&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15004202</ArticleId></ArticleIdList></Reference><Reference><Citation>Taplin CE, Barker JM. Autoantibodies in type 1 diabetes. Autoimmunity 2008;41:11&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">18176860</ArticleId></ArticleIdList></Reference><Reference><Citation>Wucherpfennig KW, Allen PM, Celada F, et al. Polyspecificity of T cell and B cell receptor recognition. Semin Immunol 2007;19:216&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034306</ArticleId><ArticleId IdType="pubmed">17398114</ArticleId></ArticleIdList></Reference><Reference><Citation>Legoux FP, Lim JB, Cauley AW, et al. CD4+ T cell tolerance to tissue-restricted self antigens is mediated by antigen-specific regulatory T cells rather than deletion. Immunity 2015;43:896&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4654997</ArticleId><ArticleId IdType="pubmed">26572061</ArticleId></ArticleIdList></Reference><Reference><Citation>Legoux FP, Lim JB, Cauley AW, et al. CD4+ T cell tolerance to tissue-restricted self antigens is mediated by antigen-specific regulatory T cells Rather than deletion. Immunity 2015;43:896&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4654997</ArticleId><ArticleId IdType="pubmed">26572061</ArticleId></ArticleIdList></Reference><Reference><Citation>Geva-Zatorsky N, Sefik E, Kua L, et al. Mining the human gut microbiota for immunomodulatory organisms. Cell 2017;168:928&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7774263</ArticleId><ArticleId IdType="pubmed">28215708</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirmer M, Smeekens SP, Vlamakis H, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 2016;167:1 125&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">27984736</ArticleId></ArticleIdList></Reference><Reference><Citation>Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 2018;378:158&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">29320654</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa NM, Farahmand A, Du L, et al. Endocrinopathies with use of cancer immunotherapies. Clin Endocrinol 2018;88:327&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5771947</ArticleId><ArticleId IdType="pubmed">28941311</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Shao X, Wang D, et al. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis. Autoimmun Rev 2017;16:756&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">28483543</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano A, Nesher G, Shoenfeld Y. Predicting post-vaccination autoimmunity: who might be at risk? Pharmacol Res 2015;92:18&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">25277820</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox RA. Disseminated lupus erythematosus: an allergic disease? Arch Path 1943;36:311&#x2013;5.</Citation></Reference><Reference><Citation>Older SA, Battafarano DF, Enzenauer RJ, et al. Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum 1999;29:131&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10622677</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>